Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $44.9B | $70.7B | $75.4B | $81.2B | $87.1B | $94.2B | $101.9B | $110.6B | $122.5B | $130.5B | $157.1B | $184.8B | $201.2B | $226.2B | $242.2B | $255.6B | $285.3B | $322.1B | $367.5B | $400.3B |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, UnitedHealth Group Incorporated's last 12-month Revenue is $398.3B, based on the financial report for Dec 31, 2024 (Q4 2024).
Over the last year, UnitedHealth Group Incorporated's Revenue growth was 8.4%. The average annual Revenue growth rates for UnitedHealth Group Incorporated have been 13.5% over the past three years, 10.5% over the past five years.
Over the last year, UnitedHealth Group Incorporated's Revenue growth was 8.4%, which is higher than industry growth of 0.1%. It indicates that UnitedHealth Group Incorporated's Revenue growth is Good.